SARS-COV-2 GENOMIC SEQUENCING

DEFINITIVE CONTRACT won by FULGENT THERAPEUTICS LLC · work in TEMPLE CITY, CA
$40,552,135
RecipientFULGENT THERAPEUTICS LLC UEI JVZDRESJLD82
Award ID75D30121C10593
Award amount$40,552,135
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Centers for Disease Control and Prevention
NAICS621511 — MEDICAL LABORATORIES
PSCQ301
Start dateMar 11, 2021
End dateMar 10, 2022
Place of performanceTEMPLE CITY, CA
Record updatedMar 21, 2022

View the official award record

More awards won by FULGENT THERAPEUTICS LLC

GERMLINE PGX MOLECULAR TESTING
Department of Veterans Affairs · $99,032,828 · Sep 30, 2024
IDIQ, GERMLINE GENETIC TESTING SERVICES FOR VETERANS HEALTH ADMINSTRATION NATIONAL ONOCOLOGY PROGRAM (NOP), YEAR 2
Department of Veterans Affairs · $6,573,600 · Sep 30, 2025
GERMLINE PGX MOLECULAR TESTING
Department of Veterans Affairs · $2,300,000 · Sep 30, 2024
GERMLINE GENETIC TESTING SERVICES
Department of Veterans Affairs · $2,055,625 · Sep 27, 2022
COVID-19 TESTING KITS AND SERVICE TO SUPPORT THE FEMA AT HOME COVID 19 TESTING PROGRAM.
Department of Homeland Security · $1,728,891 · Sep 18, 2020

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids